ARTICLE | Product Development
HBV test kitchen
How far industry is from assembling a functional cure in HBV
August 12, 2017 12:42 AM UTC
Early results for HBV monotherapies are pointing the way toward combinations that could deliver a functional cure. What remains unknown is how many components, and which ones, will prove necessary to eliminate remnants of the virus that persist on standard of care.
Data on combinations that add a single MOA to standard of care will begin to read out over the next 18 months. More complex combinations, including cocktails combining novel mechanisms, are a few years away...